Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure-Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis.
J Clin Pharmacol
; 60(1): 37-49, 2020 01.
Article
in En
| MEDLINE
| ID: mdl-31322739
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prealbumin
/
Amyloid Neuropathies, Familial
/
RNA, Small Interfering
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Pharmacol
Year:
2020
Document type:
Article
Affiliation country:
United States